Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study

Clinical Research in Cardiology

Volumn 104, Issue 3, 2015, Pages 258-271

  Becker, Michael ^a   Hundemer, Anne ^a   Zwicker, Christian ^a   Altiok, Ertunc ^a   Krohn, Thomas ^a   Mottaghy, Felix M ^a   Lente, Christina ^a   Kelm, Malte ^b   Marx, Nikolaus ^a   Hoffmann, Rainer ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cardiovascular magnetic resonance; Coronary artery disease; Echocardiography; Postmenopausal women; SPECT; Stress testing

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; GADOLINIUM PENTETATE MEGLUMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EVENT FREE SURVIVAL; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CORONARY STENOSIS; DISEASE FREE SURVIVAL; ECHOGRAPHY; EVALUATION STUDY; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; TIME;

ADENOSINE; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIMODAL IMAGING; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 84925465033     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0780-5     Document Type: Article

References (53)

1. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM, National Institutes of Health-National Heart, Lung, and Blood Institute (2004) Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institute of Health-National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 109:2993–2999
2. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED, American College of Cardiology-National Cardiovascular Data Registry Investigators (2008) Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology—National Cardiovascular Data Registry. Circulation 117:1787–1801
3. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators (2006) Insights from the NHLBI-Sponsored Women,s Ischemia Syndrome Evaluation (WISE) study: part I: gender differences, in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostics strategies. J Am Coll Cardiol 47:S4–S20
4. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators (2006) Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 47:S21–S29
5. Douglas PS, Ginsburg GS (1996) The evaluation of chest pain in women. N Engl J Med 334:1311–1315
6. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR (1989) Menopause and risk factors for coronary heart disease. N Engl J Med 321:641–646
7. Ni H, Coady S, Rosamond W, Folsom AR, Chambless L, Russell SD, Sorlie PD (2009) Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 157:46–52
8. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, Anderson JL, American College of Cardiology Foundation/American Heart Association Task Force (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012(126):e354–e471
9. Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F, Chaitman BR, Fisher LD (1979) Exercise stress testing. Correlation among history of angina, ST-segment response and prevalence of coronary-artery disease in the coronary artery surgery study (CASS). N Engl J Med 301:230–235
10. Morise AP, Dalal JN, Duval RD (1993) Frequency of oral estrogen replacement therapy in women with normal and abnormal exercise electrocardiograms and normal coronary arteries by angiogram. Am J Cardiol 72:1197–1199
11. Wenger NK (2011) Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation 126:604–611
12. Mega JL, Hochman JS, Scirica BM, Murphy SA, Sloan S, McCabe CH, Merlini P, Morrow DA (2010) Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36). Circulation 1(21):1809–1817
13. Shaw LJ, Gibbons RJ, McCallister B (2002) Gender differences in extent and severity of coronary disease in the ASS-National Cardiovascular Data Registry (abstract). J Am Coll Cardiol 39:321A
14. Johnston N, Schenck-Gustafsson K, Lagerqvist B (2011) Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J 32:1331–1336
15. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN (2009) Adverse Cardiovascular outcomes in women with nonobstructive coronary artery disease. Arch Intern Med 169:843–850
16. Bugiardini R, Yan AT, Yan RT, Fitchett D, Langer A, Manfrini O, Goodman SG, Canadian Acute Coronary Syndrome Registry I and II Investigators (2011) Factors influencing underutilization of evidence-based the rapies in women. Eur Heart J 32:1337–1344
17. Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297:611–619
18. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E, Schuler G, Fleck E, Nagel E (2002) Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. J Cardiovasc Magn Reson 4:327–339
19. Shaw LJ, Mieres JH, Hendel RH, Boden WE, Gulati M, Veledar E, Hachamovitch R, Arrighi JA, Merz CN, Gibbons RJ, Wenger NK, Heller GV, WOMEN Trial Investigators (2011) Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial. Circulation 124:1239–1249
20. Reith S, Battermann S, Hellmich M, Marx N, Burgmaier M (2014) Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions. Clin Res Cardiol 103(3):191–201
21. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for the healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542
22. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37–46
23. Picano E (2005) Economic and biological cost of cardiac imaging. Cardiovasc Ultrasound 3:11–13
24. Kwok Y, Kim C, Grady D, Segal M, Redberg R (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83:660–666
25. Sketch MH, Mohiuddin SM, Lynch JD, Zencka AE, Runco V (1975) Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol 36:169–173
26. Gulati M, Shaw LJ, Merz NB (2012) Myocardial ischemia in women-lessons from NHLBI WISE study. Clin Cardiol 35:141–148
27. Rose G, McCartney P, Reid DD (1977) Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 31:42–48
28. Cheng AS, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, Banning AP, Neubauer S, Robson MD, Selvanayagam JB (2007) Cardiovascular magnetic resonance imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 49:2440–2449
29. Shaw LJ, Burgiardini R, Bairey Merz CN (2009) Women and Ischemic heart disease. J Am Coll Cardiol 54:1561–1575
30. Klem I, Greulich S, Heitner JF, Kim H, Vogelsberg H, Kispert EM, Ambati SR, Bruch C, Parker M, Judd RM, Kim RJ, Sechtem U (2008) Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. J Am Coll Cardiol Img 1:436–445
31. Shaw LJ, Lewis JF, Hlatky MA, Hsueh WA, Kelsey SF, Klein R, Manolio TA, Sharrett AR, Tracy RP, National Heart, Lung and Blood Institute; American College of Cardiology Foundation (2004) Women’s Ischemic Syndrome Evaluation: current status and future research directions, report of the National Heart Lung Blood Institute (NHLBI) workshop, section 5: gender-related risk factors for ischemic heart disease. Circulation 109:e56c–e58c
32. Kohli P, Gulati M (2010) Exercise stress testing in women: going back to the basics. Circulation 122:2570–2580
33. Phillips LM, Mieres JH (2010) Noninvasive assessment of coronary artery disease in women: what’s next? Curr Cardiol Rep 12:147–154
34. Clark PI, Glasser SP, Lyman GH, Krug-Fite J, Root A (1988) Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol 61:197–199
35. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED (1998) Value of exercise treadmill testing in women. J Am Coll Cardiol 32:1657–1664
36. Gerber TC, Carr JJ, Arai AE, Dixon RL, Ferrari VA, Gomes AS, Heller GV, McCollough CH, McNitt-Gray MF, Mettler FA, Mieres JH, Morin RL, Yester MV (2009) Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee in Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation 119:1056–1065
37. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA (2005) The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 353:468–475
38. Kim C, Kwok YS, Heagerty P, Redberg R (2001) Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 142:934–944
39. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH (2005) Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4,234 women and 6,989 men. Eur Heart J 26:447–456
40. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, Link KM (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702
41. Jahnke C, Furundzija V, Gebker R, Manka R, Frick M, Schnackenburg B, Marx N, Paetsch I (2012) Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosin perfusion and dobutamine wall motion imaging. In J Cardiovasc Imaging 28:1087–1098
42. Coelho-Filho OR, Seabra LF, Mongeon FP, Abdullah SM, Francis SA, Blankstein R, Di Carli MF, Jerosch-Herold M, Kwong RY (2011) Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient’s sex. J Am Coll Cardiol Img 4:850–861
43. Wallace EL, Morgan TM, Walsh TF, Dall’Armellina E, Ntim W, Hamilton CA, Hundley WG (2009) Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. J Am Coll Cardiol Img 2:299–307
44. Mieres JH, Makaryus AN, Cacciabaudo JM, Donaldson D, Green SJ, Heller GV, Maddahi J, Ong L, Rampersaud T, Rosen SE, Shaw LJ, Katz S (2007) Value of electrocardiographically gated single-photon emission computed tomographic myocardial perfusion scintigraphy in a cohort of symptomatic postmenopausal women. Am J Cardiol 99:1096–1099
45. Shaw LJ, Iskandrian AE (2004) Prognostic value of stress gated SPECT in patients with known or suspected coronary artery disease. J Nucl Cardiol 11:171–185
46. Jespersen L, Abildstrøm SZ, Peña A, Hansen PR, Prescott E (2014) Predictive value of the corrected TIMI frame count in patients with suspected angina pectoris but no obstructive coronary artery disease at angiography. Clin Res Cardiol 103:381–387
47. Jespersen L, Abildstrøm SZ, Hvelplund A, Prescott E (2013) Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol 102:571–581
48. Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054–2059
49. Ndrepepa G, Tada T, Fusaro M, Cassese S, King L, Hadamitzky M, Haase HU, Schömig A, Kastrati A, Pache J (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101:1003–1011
50. Ong P, Athanasiadis A, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC (2012) Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol 101:673–681
51. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N (2003) Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 41:1863–1874
52. Elhendy A, Geleijnse ML, van Domburg RT, Nierop PR, Poldermans D, Bax JJ, TenCate FJ, Nosir YF, Ibrahim MM, Roelandt JR (1997) Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 80:1414–1418
53. Garcia EV, Faber TL, Esteves FP (2011) Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med 52:210–217